HEALTHSTORY 810· JULY 17, 2026

Access to testosterone medication in the U.S. draws scrutiny in health media

The question of who can legally obtain testosterone, a hormone medication prescribed for a range of medical conditions, surfaced this week in STAT's Morning Rounds, a free daily newsletter covering health and medicine. The newsletter…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 809$44 million Chantix settlement opens claims for health plans and patients who paid retail NEXT STORY 811 →Investors in ADMA Biologics reminded of class action deadlines

Keep reading

More from the desk.

06HEALTH

Novartis shares drop 11% on drug failure as biosimilar gap threatens $200 billion in savings

A failed clinical trial wiped nearly $30 billion from Novartis's market value this week after shares fell 11% in a single session, erasing all the gains the stock had made since the start of the year. The drug that failed, del-desiran, was…

health2 MIN

14HEALTH

EU legal adviser hands pharma a win on wastewater costs

Pharmaceutical and cosmetics companies across Europe may be off the hook for the largest share of a continent-wide water cleanup effort, after a legal adviser to the EU's top court recommended striki

health2 MIN

15HEALTH

FDA clears first drug to target muscle loss in spinal muscular atrophy

Federal regulators approved a drug on Friday for spinal muscular atrophy, a rare neurological condition where the nerve cells that signal muscles to move gradually deteriorate. The drug, Isembyld, is the first approved therapy to directly…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk